Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

Delayed Data
As of Jun 14
 +0.07 / +1.22%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 5.50. The median estimate represents a +37.69% increase from the last price of 5.81.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 37.14%
Growthannually -44.79%


Growthquarterly 4.31%
Growthannually 10.52%
Key to the earnings and sales forecast charts.